Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway

BACKGROUND: The cisplatin-resistance is still a main course for chemotherapy failure of lung cancer patients. Cisplatin-resistant cancer cells own higher malignance and exhibited increased metastatic ability, but the mechanism is not clear. In this study, we investigated the effects of Ataxia Telang...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Mingjing, Xu, Zhonghua, Xu, Weihua, Jiang, Kanqiu, Zhang, Fuquan, Ding, Qifeng, Xu, Zhonghen, Chen, Yongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454747/
https://www.ncbi.nlm.nih.gov/pubmed/30961670
http://dx.doi.org/10.1186/s13046-019-1161-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454747/
https://www.ncbi.nlm.nih.gov/pubmed/30961670
http://dx.doi.org/10.1186/s13046-019-1161-8

Ejemplares similares